Abstract

GSMN-TB, a genome-scale metabolic model of M. tuberculosis, was constructed and validated using experimental data.

Highlights

  • An impediment to the rational development of novel drugs against tuberculosis (TB) is a general paucity of knowledge concerning the metabolism of Mycobacterium tuberculosis, during infection

  • The Kyoto Encyclopedia of Genes and Genomes (KEGG) gene orthology clusters were used to map the genes between two species and transfer corresponding metabolic reactions to the TB model

  • The model incorporates most known biochemical reactions of the micro-organism and describes the biosynthetic pathways that lead to the synthesis of all of the major macromolecular components, including known virulence factors

Read more

Summary

Introduction

An impediment to the rational development of novel drugs against tuberculosis (TB) is a general paucity of knowledge concerning the metabolism of Mycobacterium tuberculosis, during infection. Tuberculosis (TB), caused by Mycobacterium tuberculosis, is one of the most important diseases in the world today, being responsible for more than 8 million cases of disease each year and approximately 3 million deaths [1,2]. A further complication in the treatment of TB is the emergence of multidrug-resistant strains of TB (both M. tuberculosis and Mycobacterium bovis) in many parts of the world [3,4]. New anti-TB drugs are urgently required that shorten the duration of treatment, that have activity against drug-resistant strains, and that target persistent cells

Objectives
Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.